Condition
Neonatal Stroke
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05648812Phase 3Recruiting
Neonatal Brain Ultrasound With CEUS and Elastography
NCT03356821Phase 1Completed
Perinatal Arterial Stroke Treated With Stromal Cells Intranasally
NCT03171818Phase 2Unknown
Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration
NCT03786497Unknown
Protecting Brains and Saving Futures - the PBSF Protocol
NCT01637129Phase 1Completed
Transcranial Magnetic Stimulation in Children With Stroke
Showing all 5 trials